MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation · 2018

Liver Transplant in Patients with Primary Sclerosing Cholangitis: Long-Term Experience of a Single Center.

Astarcioglu Ibrahim, Egeli Tufan, Unek Tarkan, Akarsu Mesut, Sagol Ozgul, Obuz Funda, Ozbilgin Mucahit, Aysal Agalar Anil, Ağalar Cihan

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

Primary sclerosing cholangitis is a chronic inflammatory disease of the intrahepatic and extrahepatic bile ducts. More than half of the patients will face end-stage liver disease and require liver transplant. Here, we describe the long-term outcomes of liver transplant in patients with primary sclerosing cholangitis at our center.

MATERIALS AND

METHODS

For this retrospective, observational study, we investigated all patients who underwent liver transplant for primary sclerosing cholangitis between January 2005 and June 2013 at the Dokuz Eylul University Hospital. Patient data were obtained from hospital records. Our inclusion criteria were patients over 18 years old and diagnosed with primary sclerosing cholangitis.

RESULTS

Of 11 patients included the study, 6 (54.5%) were male and 5 (45.5%) were female. Mean age was 40.6 ± 11.0 years (range, 23-60 y). All patients had cirrhosis due to primary sclerosing cholangitis. With regard to Child-Turcot-Pugh classification, 2 patients (18.2%) were classified as having Child-Turcot-Pugh A cirrhosis, 7 patients (63.6%) were classified as having B cirrhosis, and 2 patients (18.2%) were classified as having C cirrhosis. Mean Modified End-Stage Liver Disease score was 17.5 ± 6.1 (range, 7-25). Cholangiocarcinoma was not detected in explant pathologic examinations. Primary sclerosing cholangitis recurrence developed in 2 patients (18.1%). Three patients (27.2%) died during the follow-up period.

CONCLUSIONS

Liver transplant is a good therapeutic option for primary sclerosing cholangitis with satisfactory long-term outcomes. Liver transplant should be reserved for patients with end-stage liver disease and other conditions that significantly impair quality of life.

Для цитирования: Astarcioglu Ibrahim, Egeli Tufan, Unek Tarkan, Akarsu Mesut, Sagol Ozgul, Obuz Funda, Ozbilgin Mucahit, Aysal Agalar Anil, Ağalar Cihan. Liver Transplant in Patients with Primary Sclerosing Cholangitis: Long-Term Experience of a Single Center.. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 2018.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.